advertisement

List of abstracts related to

Listed by Classification

2.6 Aqueous humor dynamics (63 abstracts found)

94940 Non-invasive Clinical Measurement of Ocular Rigidity and Comparison to Biomechanical and Morphological Parameters in Glaucomatous and Healthy Subjects
Ma Y; Moroi SE; Roberts CJ
Frontiers in medicine 2021; 8: 701997 (IGR: 22-2)

75407 Assessment of Aqueous Humor Dynamics in the Rodent by Constant Flow Infusion
Millar JC; Phan TN; Pang IH
Methods in molecular biology (Clifton, N.J.) 2018; 1695: 109-120 (IGR: 19-2)

72441 Characterization of ocular biometrics and aqueous humor dynamics in primary angle closure suspects
Guo L; Deng Y; Fang L; Liu C; Guo T
Medicine 2017; 96: e6096 (IGR: 18-4)

71631 Aquaporin-Targeted Therapeutics: State-of-the-Field
Tradtrantip L; Jin BJ; Yao X; Anderson MO; Verkman AS
Adv Exp Med Biol 2017; 969: 239-250 (IGR: 18-3)

26334 Aqueous humor dynamics in pigment dispersion syndrome
Toris CB; Haecker NR; Teasley LA; Zhan G; Gulati V; Camras CB
Archives of Ophthalmology 2010; 128: 1115-1118 (IGR: 12-3)

26649 Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: A comparison of 1 and 6 weeks of treatment
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
Journal of Glaucoma 2010; 19: 356-364 (IGR: 12-3)

26799 Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics
Fernandez-Barrientos Y; Garcia-Feijoo J; Martinez-de-la-Casa JM; Pablo LE; Fernandez-Perez C; Garcia Sanchez J
Investigative Ophthalmology and Visual Science 2010; 51: 3327-3332 (IGR: 12-3)

25817 Intraocular hypotensive effect and action on aqueous humor dynamics of (alpha)-ergocryptine in ocular normotensive and in (alpha)-chymotrypsin-induced ocular hypertensive rabbits
Puras G; Garcia VB; Rivera G
Revista Mexicana de Ciencias Farmaceuticas 2009; 40: 22-29 (IGR: 12-2)

25123 Aqueous humor dynamics in historical perspective
Mark HH
Survey of Ophthalmology 2010; 55: 89-100 (IGR: 12-1)

21193 Mammalian aquaporins: Diverse physiological roles and potential clinical significance
Verkman AS
Expert Reviews in Molecular Medicine 2008; 10: 1-18 (IGR: 10-2)

16916 Model of pulsatile-flow of aqueous humor through the iris-lens canal
Abdulrazik M
Journal of Glaucoma 2007; 16: 129-136 (IGR: 9-1)

14907 Numerical solution of ocular fluid dynamics in a rabbit eye: parametric effects
Kumar S; Acharya S; Beuerman R; Palkama A
Annals of Biomedical Engineering 2006; 34: 530-544 (IGR: 8-4)

13788 Monkey organ-cultured anterior segments: Technique and response to H-7
Hu Y; Gabelt BT; Kaufman PL
Experimental Eye Research 2006; 82: 1100-1108 (IGR: 8-2)

13789 'What controls aqueous humour outflow resistance?'
Johnson M
Experimental Eye Research 2006; 82: 545-557 (IGR: 8-2)

12234 Increased DNA breaks and up-regulation of both G₁ and G₂ checkpoint genes p21^WAF1/CIP1 and 14-3-3σ in circulating leukocytes of glaucoma patients and vasospastic individuals
Moenkemann H; Flammer J; Wunderlich K; Breipohl W; Schild HH; Golubnitschaja O
Amino Acids 2005; 28: 199-205 (IGR: 7-2)

12309 An enhanced expression of ABC 1 transporter in circulating leukocytes as a potential molecular marker for the diagnostics of glaucoma
Yeghiazaryan K; Flammer J; Wunderlich K; Schild HH; Orgul S; Golubnitschaja O
Amino Acids 2005; 28: 207-211 (IGR: 7-2)

12184 Changes in aqueous humor dynamics with age and glaucoma
Gabelt BT; Kaufman PL
Progress in Retinal and Eye Research 2005; 24: 612-637 (IGR: 7-2)

10655 Aqueous humor dynamics
Grub M; Mielke J
Ophthalmologe 2004; 101: 357-65 (IGR: 6-2)

10281 Goldmann's equation and clinical measures of aqueous dynamics
Brubaker RF
Experimental Eye Research 2004; 78: 633-637 (IGR: 6-1)

8386 Noninvasive assessment of aqueous humor turnover in the mouse eye
Avila MY; Mitchell CH; Stone RA; Civan MM
Investigative Ophthalmology and Visual Science 2003; 44: 722-727 (IGR: 5-1)

8699 The role of protein kinase C in modulation of aqueous humor outflow facility
Khurana RN; Deng PF; Epstein DE; Rao PV
Experimental Eye Research 2003; 76: 39-47 (IGR: 5-1)

8385 Effects of ion transport and channel-blocking drugs on aqueous humor formation in isolated bovine eye
Shahidullah M; Wilson WS; Yap M; To CH
Investigative Ophthalmology and Visual Science 2003; 44: 1185-1191 (IGR: 5-1)

8853 The relationship between AQP1 expression, aqueous humor secretion and outflow in human eyes
Xu C; Song Y; Wu H
Chinese Ophthalmic Research 2003; 21: 53-55 (IGR: 5-1)

8383 Aqueous humor dynamics and the iris
Mark HH
Medical Hypotheses 2003; 60: 305-308 (IGR: 5-1)

8384 The mechanism of aqueous humour formation
To CH; Kong CW; Chan CY; Shahidullah M; Do CW
Clinical and Experimental Optometry 2002; 85: 335-349 (IGR: 5-1)

8187 The mechanism of increasing outflow facility during washout in the bovine eye
Overby D; Gong H; Qiu G; Freddo TF; Johnson M
Investigative Ophthalmology and Visual Science 2002; 43: 3455-3464 (IGR: 4-3)

8184 Vascular endothelial growth factor is increased in aqueous humor of glaucomatous eyes
Hu DN; Ritch R; Liebmann JM; Liu Y; Cheng B; Hu MS
Journal of Glaucoma 2002; 11: 406-410 (IGR: 4-3)

8345 Circadian variations of transforming growth factor-β₂ and basic fibroblast growth factor in the rabbit aqueous humor
Liu JH
Current Eye Research 2002; 24: 75-80 (IGR: 4-3)

8185 Detection of connective tissue growth factor in human aqueous humor
Van Setten G; Blalock TD; Grotendorst G; Schultz GS
Ophthalmic Research 2002; 34: 306-308 (IGR: 4-3)

8352 Time-dependent effects of sympathetic denervation on aqueous humor dynamics and choroidal blood flow in rabbits
Zhan G; Lee P; Ball D; Mayberger C; Tafoya M; Camras C; Toris C
Current Eye Research 2002; 25: 99-105 (IGR: 4-3)

3405 Identification of the mouse uveoscleral outflow pathway using fluorescent dextran
Lindsey JD; Weinreb RN
Investigative Ophthalmology and Visual Science 2002; 43: 2201-2205 (IGR: 4-2)

3406 Aqueous humor dynamics in ocular hypertensive patients
Toris CB; Koepsell SA; Yablonski ME; Camras CB
Journal of Glaucoma 2002; 11: 253-258 (IGR: 4-2)

3389 Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes
Ochiai Y; Ochiai H
Japanese Journal of Ophthalmology 2002; 46: 249-253 (IGR: 4-2)

6615 Aqueous humor in primary open-angle glaucoma contains an increased level of CD44S
Knepper PA; Mayanil CSK; Goossens W; Wertz RD; Holgren C; Ritch R; Allingham RR
Investigative Ophthalmology and Visual Science 2002; 43: 133-139 (IGR: 4-1)

6623 Modeling passive mechanical interaction between aqueous humor and iris
Heys JJ; Barocas VH; Taravella MJ
Journal of Biomechanical Engineering 2001; 123: 540-547 (IGR: 4-1)

6624 Endothelin 1 levels in the aqueous humor of dogs with glaucoma
Kallberg ME; Brooks DE; Garcia-Sanchez GA; Komaromy AM; Szabo NJ
Journal of Glaucoma 2002; 11: 105-109 (IGR: 4-1)

6625 Biochemical markers of the L-arginine-nitric oxide pathway in the aqueous humour in glaucoma patients
Kotikoski H; Moilanen E; Vapaatalo H; Aine E
Acta Ophthalmologica Scandinavica 2002; 80: 191-195 (IGR: 4-1)

6626 Central imidazoline (I₁) receptors modulate aqueous hydrodynamics
Ogidigben MJ; Potter DE
Current Eye Research 2001; 22: 358-366 (IGR: 4-1)

18506 Acute effects of insulin on aqueous humor flow in patients with type 1 diabetes
Lane JT; Toris CB; Nakhle SN; Chacko DM; Wang YL; Yablonski ME
American Journal of Ophthalmology 2001; 132: 321-327 (IGR: 3-3)

18505 Fluorophotometric determination of aqueous humor flow rate in clinically normal dogs
Ward DA; Cawrse MA; Hendrix DV
American Journal of Veterinary Research 2001; 62: 853-858 (IGR: 3-3)

6319 Giant vacuole survival time and implications for aqueous humor outflow
Brilakis HS; Johnson DH
Journal of Glaucoma 2001; 10: 277-283 (IGR: 3-2)

6326 Capillary electrophoresis of aqueous glutathione in glaucoma
Della Valle V; Ricci R; Morara M; Muscari C; Di Silvestre L; Scorolli L; Scorolli LG; Guarnieri C; Meduri R
Annali di Ottalmologia e Clinica Oculistica 2001; 127: 65-71 (IGR: 3-2)

6327 Hepatocyte growth factor is increased in the aqueous humor of glaucomatous eyes
Hu DN; Ritch R
Journal of Glaucoma 2001; 10: 152-157 (IGR: 3-2)

6328 The quantification of endogenous steroids in bovine aqueous humour and vitreous humour using isotope dilution GC-NCI-MS
Iqbal Z; Midgely JM; Watson DG
Journal of Pharmacological and Biomedical Analysis 2001; 24: 535-543 (IGR: 3-2)

18943 Capillary electrophoresys of aqueous glutathione in glaucoma
Della Valle V; Ricci R; Morara M; Muscari C; Di Silvestre L; Scorolli L; Scorolli LG; Guarnieri C; Meduri R
Annali di Ottalmologia e Clinica Oculistica 2001; 127: 65-67 (IGR: 3-1)

18944 Transforming growth factor-β2 levels in aqueous humor of glaucomatous eyes
Inatani M; Tanihara H; Katsuta H; Honjo M; Kido N; Honda Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2001; 239: 109-113 (IGR: 3-1)

18945 Role of tissue growth factors in aqueous humor homeostasis
Welge-Lubetaen U; May CA; Neubauer AS; Priglinger S
Current Opinions in Ophthalmology 2001; 12: 94-99 (IGR: 3-1)

15737 Aqueous humor nitric oxide levels differ in patients with different types of glaucoma
Chang CJ; Chiang CH; Chow JC; Lu D-W
Journal of Ocular Pharmacology and Therapeutics 2000; 16: 399-406 (IGR: 2-3)

15981 Uveoscleral Outflow: The other outflow pathway.
Weinreb B
Journal of Glaucoma 2000; 9: 343-345 (IGR: 2-3)

5981 Aqueous outflow pathway imaging in the rabbit with fluorescein and indocyanine green
Roy S; Boldea R; Perez D; Curchod M; Mermoud A
Klinische Monatsblätter für Augenheilkunde 2000; 216: 305-308 (IGR: 2-2)

5987 Chloride secretion by bovine ciliary epithelium: a model of aqueous humor formation
Do CW; To CH
Investigative Ophthalmology and Visual Science 2000; 41: 1853-1860 (IGR: 2-2)

5988 Formation of the aqueous humor
Macknight AD; McLaughlin CW; Peart D; Purves RD; Carre DA; Civan MM
Clinical and Experimental Pharmacology and Physiology 2000; 27: 100-106 (IGR: 2-2)

5989 Assessment of ascorbate ocular disposition in the conscious rabbit: an approach using the microdialysis technique
Rittenhouse KD; Peiffer RL Jr; Pollack GM
Current Eye Research 2000; 20: 351-360 (IGR: 2-2)

5586 Cytoskeletal involvement in the regulation of aqueous humor outflow
Tian B; Geiger B; Epstein DL; Kaufman PL
Investigative Ophthalmology and Visual Science 2000; 41: 619-623 (IGR: 2-1)

5588 Micropurification of beta- and gamma-crystallins from rabbit aqueous humor
Leone MG; Saso L; Cheng CY; Silvestrini B
International Journal of Biological Macromolecules 1999; 26:167-171 (IGR: 2-1)

5589 Circadian variations of prostaglandins in the rabbit aqueous humor
Liu JH
Journal of Ocular Pharmacology and Therapeutics 2000; 16:49-54 (IGR: 2-1)

5590 Aqueous humor dynamics in monkeys with laser-induced glaucoma
Toris CB; Zhan GL; Wang YL; Zhao J; McLaughlin MA; Camras CB; Yablonski ME
Journal of Ocular Pharmacology and Therapeutics 2000; 16:19-27 (IGR: 2-1)

5591 X-ray microanalytical and morphological observations of aqueous humor from cataract human eyes with and without diabetes mellitus
Wroblewski R; Zaczek A
Journal of Submicroscopic Cytology and Pathology 1999; 31:367-373 (IGR: 2-1)

15355 Specific aqueous humor factors induce activation of regulatory T cells
Nishida T; Taylor AW
Investigative Ophthalmology and Visual Science 1999; 40: 2268-2274 (IGR: 1-3)

5194 Effect of aqueous humor on apoptosis of inflammatory cell types.
D'Orazio TJ; DeMarco BM; Mayhew ES; Niederkorn JY
Investigative Ophthalmology and Visual Science 1999; 40: 1418-1426 (IGR: 1-2)

5195 Localization of nitric oxide synthase isoforms in porcine ocular tissues
Meyer P; Champion C; Schlötzer-Schrehardt U; Flammer J; Haefliger I
Current Eye Research 1999; 18: 375-380 (IGR: 1-2)

5196 Excimer laser effects on outflow facility and outflow pathway morphology.
Schuman JS; Chang W; Wang N; de Kater AW; Allingham RR
Investigative Ophthalmology and Visual Science 1999; 40: 1676-1680 (IGR: 1-2)

9.2.1 Ocular hypertension (584 abstracts found)

94864 Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
Del Buey-Sayas MÁ
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94442 High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis
Ma T
British Journal of Ophthalmology 2022; 106: 1520-1523 (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Scott AT
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94778 Optical Coherence Tomography Evaluation of Peripapillary and Macular Structure Changes in Pre-perimetric Glaucoma, Early Perimetric Glaucoma, and Ocular Hypertension: A Systematic Review and Meta-Analysis
Tong Y
Frontiers in medicine 2021; 8: 696004 (IGR: 22-2)

94833 miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks
Raga-Cervera J; Bolarin JM
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94442 High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis
Sims JL
British Journal of Ophthalmology 2022; 106: 1520-1523 (IGR: 22-2)

94778 Optical Coherence Tomography Evaluation of Peripapillary and Macular Structure Changes in Pre-perimetric Glaucoma, Early Perimetric Glaucoma, and Ocular Hypertension: A Systematic Review and Meta-Analysis
Wang T
Frontiers in medicine 2021; 8: 696004 (IGR: 22-2)

94864 Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
Lanchares-Sancho E
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Kanaster K
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94442 High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis
Bennett S
British Journal of Ophthalmology 2022; 106: 1520-1523 (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Kaizer AM
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94864 Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
Campins-Falcó P
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94778 Optical Coherence Tomography Evaluation of Peripapillary and Macular Structure Changes in Pre-perimetric Glaucoma, Early Perimetric Glaucoma, and Ocular Hypertension: A Systematic Review and Meta-Analysis
Zhang X
Frontiers in medicine 2021; 8: 696004 (IGR: 22-2)

94833 miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks
Millan JM; Garcia-Medina JJ
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94778 Optical Coherence Tomography Evaluation of Peripapillary and Macular Structure Changes in Pre-perimetric Glaucoma, Early Perimetric Glaucoma, and Ocular Hypertension: A Systematic Review and Meta-Analysis
He Y
Frontiers in medicine 2021; 8: 696004 (IGR: 22-2)

94864 Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
Pinazo-Durán MD
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94442 High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis
Chew S
British Journal of Ophthalmology 2022; 106: 1520-1523 (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Young CC
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94864 Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
Peris-Martínez C
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94833 miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks
Pedrola L
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94864 Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population
Peris-Martínez C
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94442 High rate of conversion from ocular hypertension to glaucoma in subjects with uveitis
Niederer RL
British Journal of Ophthalmology 2022; 106: 1520-1523 (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Pantcheva MB
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94778 Optical Coherence Tomography Evaluation of Peripapillary and Macular Structure Changes in Pre-perimetric Glaucoma, Early Perimetric Glaucoma, and Ocular Hypertension: A Systematic Review and Meta-Analysis
Jiang B
Frontiers in medicine 2021; 8: 696004 (IGR: 22-2)

94833 miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks
Abellán-Abenza J
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Ertel MK; Kahook MY
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94833 miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks
Valero-Vello M; Valero-Vello M; Sanz-González SM
Journal of clinical medicine 2021; 10: (IGR: 22-2)

94861 The Utility of iCare HOME Tonometry for Detection of Therapy-Related Intraocular Pressure Changes in Glaucoma and Ocular Hypertension
Seibold LK
Ophthalmology. Glaucoma 2022; 5: 85-93 (IGR: 22-2)

94833 miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis Networks
O'Connor JE; Galarreta-Mira D; Galarreta-Mira D; Bendala-Tufanisco E; Mayordomo-Febrer A; Pinazo-Durán MD; Zanón-Moreno V
Journal of clinical medicine 2021; 10: (IGR: 22-2)

90902 Intraocular pressure reduction in glaucoma: Does every mmHg count?
Jayaram H
Taiwan journal of ophthalmology 2020; 10: 255-258 (IGR: 21-4)

90485 Diagnostic ability of OCT parameters and retinal ganglion cells count in identification of glaucoma in myopic preperimetric eyes
Rolle T; Bonetti B; Mazzucco A; Dallorto L
BMC Ophthalmology 2020; 20: 373 (IGR: 21-3)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86193 The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma
Hopf S
International Ophthalmology 2020; 40: 1403-1410 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Cousins CC
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Kelly SR
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Bak E; Bak E
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Ho H
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86661 Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
Kim JA
Investigative Ophthalmology and Visual Science 2020; 61: 4 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Pan BX
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Daas A
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Khawaja AP
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Kim YW
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86661 Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
Kim TW
Investigative Ophthalmology and Visual Science 2020; 61: 4 (IGR: 21-2)

86193 The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma
Schwantuschke D
International Ophthalmology 2020; 40: 1403-1410 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Ha A
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86661 Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
Lee EJ
Investigative Ophthalmology and Visual Science 2020; 61: 4 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Ho J
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86193 The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma
Pfeiffer N
International Ophthalmology 2020; 40: 1403-1410 (IGR: 21-2)

86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Bryan SR
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Chou JC
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Alaghband P
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86661 Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
Girard MJA
Investigative Ophthalmology and Visual Science 2020; 61: 4 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Kim YK
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Shen LQ
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86193 The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma
Koenig J
International Ophthalmology 2020; 40: 1403-1410 (IGR: 21-2)

86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Azuara-Blanco A
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Gordon MO
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86193 The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma
Bell K
International Ophthalmology 2020; 40: 1403-1410 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Galvis EA
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86661 Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
Mari JM
Investigative Ophthalmology and Visual Science 2020; 61: 4 (IGR: 21-2)

86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Sparrow JM
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Park KH
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86193 The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma
Hoffmann EM
International Ophthalmology 2020; 40: 1403-1410 (IGR: 21-2)

86552 Progression from ocular hypertension to visual field loss in the English hospital eye service
Crabb DP
British Journal of Ophthalmology 2020; 104: 1406-1411 (IGR: 21-2)

86566 Pre-perimetric Open Angle Glaucoma with Young Age of Onset: Natural Clinical Course and Risk Factors for Progression
Jeoung JW
American Journal of Ophthalmology 2020; 216: 121-131 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Kass MA
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
de Antonio Ramirez A
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Ritch R
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Grassi P; Lim R
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

86806 Densitometric Profiles of Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
Pasquale LR
American Journal of Ophthalmology 2020; 217: 10-19 (IGR: 21-2)

86671 Intraocular pressure changes following topical ocular hypotensive medications washout
Lim KS
British Journal of Ophthalmology 2021; 105: 205-209 (IGR: 21-2)

85219 Spatial contrast sensitivity in patients with primary open-angle glaucoma and ocular hypertension
Ekgardt VF
Vestnik Oftalmologii 2020; 136: 25-35 (IGR: 21-1)

85054 Peripapillary Vessel Density In Unilateral Preperimetric Glaucoma
Mangouritsas G; Koutropoulou N
Clinical Ophthalmology 2019; 13: 2511-2519 (IGR: 21-1)

85219 Spatial contrast sensitivity in patients with primary open-angle glaucoma and ocular hypertension
Dorofeev DA
Vestnik Oftalmologii 2020; 136: 25-35 (IGR: 21-1)

85054 Peripapillary Vessel Density In Unilateral Preperimetric Glaucoma
Ragkousis A; Boutouri E; Diagourtas A
Clinical Ophthalmology 2019; 13: 2511-2519 (IGR: 21-1)

81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Tang W
Medicine 2019; 98: e16597 (IGR: 20-3)

80878 Color visual acuity in preperimetric glaucoma and open-angle glaucoma
Ouchi J; Kunikata H
PLoS ONE 2019; 14: e0215290 (IGR: 20-3)

81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Zhang F; Liu K
Medicine 2019; 98: e16597 (IGR: 20-3)

80878 Color visual acuity in preperimetric glaucoma and open-angle glaucoma
Omodaka K
PLoS ONE 2019; 14: e0215290 (IGR: 20-3)

81446 Efficacy and safety of prostaglandin analogues in primary open-angle glaucoma or ocular hypertension patients: A meta-analysis
Duan X
Medicine 2019; 98: e16597 (IGR: 20-3)

80878 Color visual acuity in preperimetric glaucoma and open-angle glaucoma
Sato H; Ito A; Aizawa N; Tanaka Y; Ichikawa K; Nakazawa T
PLoS ONE 2019; 14: e0215290 (IGR: 20-3)

79944 Evaluation of spectral domain optical coherence tomography parameters in discriminating preperimetric glaucoma from high myopia
Xu XY
International Journal of Ophthalmology 2019; 12: 58-65 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Hong SW
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

80039 Diagnostic ability of macular ganglion cell asymmetry in Preperimetric Glaucoma
Chen MJ
BMC Ophthalmology 2019; 19: 12 (IGR: 20-2)

79824 Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients
de Queiroz Mendonca C
Leukemia Research 2019; 76: 24-28 (IGR: 20-2)

79674 Linear discriminant score for differentiating early primary open angle glaucoma from glaucoma suspects
Deshpande GA
Indian Journal of Ophthalmology 2019; 67: 75-81 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Tanihara H
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Wang Q
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

80007 Ocular hypertension secondary to high endogenous steroid load in Cushing's disease
Habib SN
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Lazreg S
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79674 Linear discriminant score for differentiating early primary open angle glaucoma from glaucoma suspects
Bawankule PK
Indian Journal of Ophthalmology 2019; 67: 75-81 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Kakuda T
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Perez CI
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

79824 Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients
Freire MV
Leukemia Research 2019; 76: 24-28 (IGR: 20-2)

79944 Evaluation of spectral domain optical coherence tomography parameters in discriminating preperimetric glaucoma from high myopia
Xiao H
International Journal of Ophthalmology 2019; 12: 58-65 (IGR: 20-2)

80007 Ocular hypertension secondary to high endogenous steroid load in Cushing's disease
Lin Z
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Koenigsman H
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Merad Z
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

80039 Diagnostic ability of macular ganglion cell asymmetry in Preperimetric Glaucoma
Yang HY; Yang HY
BMC Ophthalmology 2019; 19: 12 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Yang H
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Sano T
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Nouri MT
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

80007 Ocular hypertension secondary to high endogenous steroid load in Cushing's disease
Puvanachandra N
British Medical Journal (Clinical Research Edition) Case Reports 2019; 12: (IGR: 20-2)

80039 Diagnostic ability of macular ganglion cell asymmetry in Preperimetric Glaucoma
Chang YF
BMC Ophthalmology 2019; 19: 12 (IGR: 20-2)

79674 Linear discriminant score for differentiating early primary open angle glaucoma from glaucoma suspects
Raje DV
Indian Journal of Ophthalmology 2019; 67: 75-81 (IGR: 20-2)

79944 Evaluation of spectral domain optical coherence tomography parameters in discriminating preperimetric glaucoma from high myopia
Luo JY
International Journal of Ophthalmology 2019; 12: 58-65 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Masis M
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

79824 Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients
Viana SS; Silva Tavares MKG
Leukemia Research 2019; 76: 24-28 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Ren R
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Feinstein M
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

80039 Diagnostic ability of macular ganglion cell asymmetry in Preperimetric Glaucoma
Hsu CC
BMC Ophthalmology 2019; 19: 12 (IGR: 20-2)

79944 Evaluation of spectral domain optical coherence tomography parameters in discriminating preperimetric glaucoma from high myopia
Liu X
International Journal of Ophthalmology 2019; 12: 58-65 (IGR: 20-2)

79674 Linear discriminant score for differentiating early primary open angle glaucoma from glaucoma suspects
Chakraborty M
Indian Journal of Ophthalmology 2019; 67: 75-81 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Kanno T
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Garout R; Derdour A
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Mora M
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Imada R
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

79824 Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients
Almeida Silva WM
Leukemia Research 2019; 76: 24-28 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Reynaud J
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

80039 Diagnostic ability of macular ganglion cell asymmetry in Preperimetric Glaucoma
Ko YC
BMC Ophthalmology 2019; 19: 12 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Mora M; Lin SC
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Shingaki W
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

80039 Diagnostic ability of macular ganglion cell asymmetry in Preperimetric Glaucoma
Liu CJ
BMC Ophthalmology 2019; 19: 12 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Ghroud N
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79824 Ocular manifestations in acute lymphoblastic leukemia: A five-year cohort study of pediatric patients
Cipolotti R
Leukemia Research 2019; 76: 24-28 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Kinast RM
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Kherroubi R
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Mansberger SL
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79743 Post-phacoemulsification iris changes in eyes with glaucoma or glaucoma suspect status
Hsia YC
PLoS ONE 2018; 13: e0208776 (IGR: 20-2)

80062 Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Gunji R
Advances in Therapy 2019; 36: 333-343 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Meziane M
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Fortune B; Demirel S
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Belkacem S
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Gardiner SK
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Ouhadj O; Baudouin C
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79477 Glaucoma Specialist Detection of Optical Coherence Tomography Suspicious Rim Tissue in Glaucoma and Glaucoma Suspect Eyes
Burgoyne CF
American Journal of Ophthalmology 2019; 199: 28-43 (IGR: 20-2)

79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Tiar M
Journal Français d'Ophtalmologie 2018; 41: 945-954 (IGR: 20-2)

79152 The assessment of structural changes on optic nerve head and macula in primary open angle glaucoma and ocular hypertension
Dagdelen K
International Journal of Ophthalmology 2018; 11: 1631-1637 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
Moreno-Montañés J
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Song XY
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
García-Nieva A
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Puyang Z
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

79152 The assessment of structural changes on optic nerve head and macula in primary open angle glaucoma and ocular hypertension
Dirican E
International Journal of Ophthalmology 2018; 11: 1631-1637 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
Osio IA
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Chen AH
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
Guarnieri A
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Zhao J; Li XJ
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
Morilla-Grasa A
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Chen YY
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
García-Granero M
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Tang WJ
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

79088 Evaluation of RETICs Glaucoma Diagnostic Calculators in Preperimetric Glaucoma
Antón A
Translational vision science & technology 2018; 7: 13 (IGR: 20-1)

79097 Diffusion Tensor Imaging Detects Microstructural Differences of Visual Pathway in Patients With Primary Open-Angle Glaucoma and Ocular Hypertension
Zhang YY
Frontiers in human neuroscience 2018; 12: 426 (IGR: 20-1)

78191 Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management
Călugăru D
International Journal of Ophthalmology 2018; 11: 1173-1178 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Geyman LS
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78037 Long-term follow-up of retinal nerve fiber layer cleavages in glaucoma patients and suspects
Hsia Y
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1945-1952 (IGR: 19-4)

78162 Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection
Jabbour E
Ophthalmologica 2018; 240: 129-134 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Mancino R
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

77879 Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Suzuki K
Advances in Therapy 2018; 35: 796-808 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Misiuk-Hojlo M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

77879 Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Otsuka N
Advances in Therapy 2018; 35: 796-808 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Pomorska M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78162 Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection
Azar G
Ophthalmologica 2018; 240: 129-134 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Di Carlo E
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

78191 Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management
Călugăru M
International Journal of Ophthalmology 2018; 11: 1173-1178 (IGR: 19-4)

78037 Long-term follow-up of retinal nerve fiber layer cleavages in glaucoma patients and suspects
Su CC
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1945-1952 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Suwan Y
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Mulak M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78037 Long-term follow-up of retinal nerve fiber layer cleavages in glaucoma patients and suspects
Wang TH
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1945-1952 (IGR: 19-4)

78191 Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management
Ţălu Ş
International Journal of Ophthalmology 2018; 11: 1173-1178 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Garg R
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

77879 Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Hizaki H
Advances in Therapy 2018; 35: 796-808 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Napoli D
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

78162 Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection
Antoun J
Ophthalmologica 2018; 240: 129-134 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Field MG
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Martucci A
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

78162 Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection
Kourie HR
Ophthalmologica 2018; 240: 129-134 (IGR: 19-4)

77879 Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Hashimoto M
Advances in Therapy 2018; 35: 796-808 (IGR: 19-4)

78037 Long-term follow-up of retinal nerve fiber layer cleavages in glaucoma patients and suspects
Yang CM
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1945-1952 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Rekas M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

77879 Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Kuwayama Y
Advances in Therapy 2018; 35: 796-808 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Wierzbowska J
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Mauro A
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

78037 Long-term follow-up of retinal nerve fiber layer cleavages in glaucoma patients and suspects
Huang JY
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 1945-1952 (IGR: 19-4)

78162 Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection
Abdelmassih Y
Ophthalmologica 2018; 240: 129-134 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Krawitz BD
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Rp S
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Prost M
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

77879 Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension

Advances in Therapy 2018; 35: 796-808 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Mo S
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78162 Incidence and Risk Factors of Ocular Hypertension following Pars Plana Vitrectomy and Silicone Oil Injection
Jalkh A
Ophthalmologica 2018; 240: 129-134 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Pinhas A
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Wasyluk J
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Cesareo M
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Ritch R
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78273 Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Nucci C
Open Ophthalmology Journal 2018; 12: 110-120 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Lubinski W
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

77687 Noninvasive Detection of Mitochondrial Dysfunction in Ocular Hypertension and Primary Open-angle Glaucoma
Rosen RB
Journal of Glaucoma 2018; 27: 592-599 (IGR: 19-4)

78109 The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension
Podboraczynska-Jodko K; Romaniuk W; Kinasz R; Ortyl-Markiewicz R; Mocko L; Zaleska-Zmijewska A; Rokicki D; Baudouin C
European Journal of Ophthalmology 2018; 0: 1120672118785280 (IGR: 19-4)

76631 Long-term evaluation of ocular hypertension with primary angle closure and primary open angles
Sihota R
International Ophthalmology 2019; 39: 803-812 (IGR: 19-3)

77233 Variability of vertical cup to disc ratio measurement and the effects of glaucoma 5-year risk estimation in untreated ocular hypertensive eyes
Chan PPM
British Journal of Ophthalmology 2019; 103: 361-368 (IGR: 19-3)

77275 A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma
Phu J
Translational vision science & technology 2018; 7: 17 (IGR: 19-3)

76799 Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis
Kaushik S
Indian Journal of Ophthalmology 2018; 66: 511-516 (IGR: 19-3)

77101 Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Hoy SM
Drugs 2018; 78: 773-780 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Xie X
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

76618 What We Have Learned From the Ocular Hypertension Treatment Study
Gordon MO
American Journal of Ophthalmology 2018; 189: xxiv-xxvii (IGR: 19-3)

76631 Long-term evaluation of ocular hypertension with primary angle closure and primary open angles
Selvan H
International Ophthalmology 2019; 39: 803-812 (IGR: 19-3)

77275 A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma
Khuu SK
Translational vision science & technology 2018; 7: 17 (IGR: 19-3)

76799 Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis
Kataria P
Indian Journal of Ophthalmology 2018; 66: 511-516 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Chen W
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

77233 Variability of vertical cup to disc ratio measurement and the effects of glaucoma 5-year risk estimation in untreated ocular hypertensive eyes
Chiu VSM
British Journal of Ophthalmology 2019; 103: 361-368 (IGR: 19-3)

76618 What We Have Learned From the Ocular Hypertension Treatment Study
Kass MA
American Journal of Ophthalmology 2018; 189: xxiv-xxvii (IGR: 19-3)

77275 A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma
Bui BV
Translational vision science & technology 2018; 7: 17 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Li Z
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

76631 Long-term evaluation of ocular hypertension with primary angle closure and primary open angles
Sharma A
International Ophthalmology 2019; 39: 803-812 (IGR: 19-3)

77233 Variability of vertical cup to disc ratio measurement and the effects of glaucoma 5-year risk estimation in untreated ocular hypertensive eyes
Wong MOI
British Journal of Ophthalmology 2019; 103: 361-368 (IGR: 19-3)

76799 Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis
Jain V
Indian Journal of Ophthalmology 2018; 66: 511-516 (IGR: 19-3)

76631 Long-term evaluation of ocular hypertension with primary angle closure and primary open angles
Gupta A
International Ophthalmology 2019; 39: 803-812 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Thomas R
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

76799 Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis
Joshi G
Indian Journal of Ophthalmology 2018; 66: 511-516 (IGR: 19-3)

77275 A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma
Kalloniatis M
Translational vision science & technology 2018; 7: 17 (IGR: 19-3)

76799 Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis
Raj S
Indian Journal of Ophthalmology 2018; 66: 511-516 (IGR: 19-3)

76631 Long-term evaluation of ocular hypertension with primary angle closure and primary open angles
Gupta V
International Ophthalmology 2019; 39: 803-812 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Li Y
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

76799 Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis
Pandav SS
Indian Journal of Ophthalmology 2018; 66: 511-516 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Xian J
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

76631 Long-term evaluation of ocular hypertension with primary angle closure and primary open angles
Dada T; Upadhyay AD
International Ophthalmology 2019; 39: 803-812 (IGR: 19-3)

76777 Noninvasive evaluation of cerebrospinal fluid pressure in ocular hypertension: a preliminary study
Yang D; Wang H; Zhang S; Kang Z; Wang N;
Acta Ophthalmologica 2018; 96: e570-e576 (IGR: 19-3)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Cifuentes-Canorea P
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Aizawa N
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Susanna CN
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75262 Usefulness of 10-2 Matrix Frequency Doubling Technology Perimetry for Detecting Central Visual Field Defects in Preperimetric Glaucoma Patients
Jung Y
Scientific reports 2017; 7: 14622 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Diekmann T
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75524 Can Probability Maps of Swept-Source Optical Coherence Tomography Predict Visual Field Changes in Preperimetric Glaucoma?
Lee WJ
Investigative Ophthalmology and Visual Science 2017; 58: 6257-6264 (IGR: 19-2)

75758 Variation in Intraocular Pressure and the Risk of Developing Open-Angle Glaucoma: The Los Angeles Latino Eye Study
Jiang X
American Journal of Ophthalmology 2018; 188: 51-59 (IGR: 19-2)

75524 Can Probability Maps of Swept-Source Optical Coherence Tomography Predict Visual Field Changes in Preperimetric Glaucoma?
Kim YK
Investigative Ophthalmology and Visual Science 2017; 58: 6257-6264 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Schrems-Hoesl LM
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75262 Usefulness of 10-2 Matrix Frequency Doubling Technology Perimetry for Detecting Central Visual Field Defects in Preperimetric Glaucoma Patients
Park HL
Scientific reports 2017; 7: 14622 (IGR: 19-2)

75758 Variation in Intraocular Pressure and the Risk of Developing Open-Angle Glaucoma: The Los Angeles Latino Eye Study
Torres M
American Journal of Ophthalmology 2018; 188: 51-59 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Kunikata H
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Ruiz-Medrano J
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Diniz-Filho A
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75758 Variation in Intraocular Pressure and the Risk of Developing Open-Angle Glaucoma: The Los Angeles Latino Eye Study
Varma R
American Journal of Ophthalmology 2018; 188: 51-59 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Shiga Y
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Mardin CY
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Gutierrez-Bonet R
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75524 Can Probability Maps of Swept-Source Optical Coherence Tomography Predict Visual Field Changes in Preperimetric Glaucoma?
Jeoung JW
Investigative Ophthalmology and Visual Science 2017; 58: 6257-6264 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Daga FB
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75262 Usefulness of 10-2 Matrix Frequency Doubling Technology Perimetry for Detecting Central Visual Field Defects in Preperimetric Glaucoma Patients
Park YR
Scientific reports 2017; 7: 14622 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Laemmer R
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Peña-Garcia P
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75758 Variation in Intraocular Pressure and the Risk of Developing Open-Angle Glaucoma: The Los Angeles Latino Eye Study

American Journal of Ophthalmology 2018; 188: 51-59 (IGR: 19-2)

75524 Can Probability Maps of Swept-Source Optical Coherence Tomography Predict Visual Field Changes in Preperimetric Glaucoma?
Park KH
Investigative Ophthalmology and Visual Science 2017; 58: 6257-6264 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Susanna BN
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75262 Usefulness of 10-2 Matrix Frequency Doubling Technology Perimetry for Detecting Central Visual Field Defects in Preperimetric Glaucoma Patients
Park CK
Scientific reports 2017; 7: 14622 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Tsuda S
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Zhu F
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Yokoyama Y
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Saenz-Frances F
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Horn FK
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Ogata NG
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Garcia-Feijoo J
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Kruse FE
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Omodaka K
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

75979 Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients
Martinez-de-la-Casa JM
PLoS ONE 2018; 13: e0196112 (IGR: 19-2)

75436 Predictive Factors for Visual Field Conversion: Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography
Schrems WA
Journal of Glaucoma 2018; 27: 157-163 (IGR: 19-2)

75661 A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor for Predicting Development of Glaucoma
Medeiros FA
American Journal of Ophthalmology 2018; 187: 148-152 (IGR: 19-2)

75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Yasui T; Kato K; Kurashima H; Miyamoto E; Hashimoto M; Nakazawa T
PLoS ONE 2017; 12: e0188692 (IGR: 19-2)

74766 Evaluation of spectral domain optical coherence tomography parameters in ocular hypertension, preperimetric, and early glaucoma
Aydogan T
Indian Journal of Ophthalmology 2017; 65: 1143-1150 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Konstantakopoulou E
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Triolo G
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Arai T
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Rabiolo A
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Gazzard G
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74766 Evaluation of spectral domain optical coherence tomography parameters in ocular hypertension, preperimetric, and early glaucoma
Akçay BİS
Indian Journal of Ophthalmology 2017; 65: 1143-1150 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Murata H
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74766 Evaluation of spectral domain optical coherence tomography parameters in ocular hypertension, preperimetric, and early glaucoma
Kardeş E
Indian Journal of Ophthalmology 2017; 65: 1143-1150 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Matsuura M
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Shemonski ND
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Vickerstaff V
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74766 Evaluation of spectral domain optical coherence tomography parameters in ocular hypertension, preperimetric, and early glaucoma
Ergin A
Indian Journal of Ophthalmology 2017; 65: 1143-1150 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Fard A
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Usui T
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Jiang Y
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74062 The association between ocular surface measurements with visual field reliability indices and gaze tracking results in preperimetric glaucoma
Asaoka R
British Journal of Ophthalmology 2018; 102: 525-530 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Nathwani N
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Di Matteo F
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Hunter R
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Sacconi R; Bettin P
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics
Ambler G; Bunce C
British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Magazzeni S
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

74532 The laser in glaucoma and ocular hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics

British Journal of Ophthalmology 2018; 102: 599-603 (IGR: 19-1)

74753 Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
Querques G; Vazquez LE; Barboni P; Bandello F
Investigative Ophthalmology and Visual Science 2017; 58: 5713-5722 (IGR: 19-1)

73069 Comparison of isolated-check visual evoked potential and standard automated perimetry in early glaucoma and high-risk ocular hypertension
Chen XW
International Journal of Ophthalmology 2017; 10: 599-604 (IGR: 18-4)

72765 Diagnostic Ability of Wide-field Retinal Nerve Fiber Layer Maps Using Swept-Source Optical Coherence Tomography for Detection of Preperimetric and Early Perimetric Glaucoma
Lee WJ
Journal of Glaucoma 2017; 26: 577-585 (IGR: 18-4)

72749 Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma
Kim HJ
Japanese Journal of Ophthalmology 2017; 61: 307-313 (IGR: 18-4)

73168 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
De Moraes CG
Ophthalmology 2017; 124: 1449-1456 (IGR: 18-4)

73146 Comparison of matrix frequency-doubling technology perimetry and standard automated perimetry in monitoring the development of visual field defects for glaucoma suspect eyes
Hu R; Wang C
PLoS ONE 2017; 12: e0178079 (IGR: 18-4)

73168 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
Hood DC
Ophthalmology 2017; 124: 1449-1456 (IGR: 18-4)

72765 Diagnostic Ability of Wide-field Retinal Nerve Fiber Layer Maps Using Swept-Source Optical Coherence Tomography for Detection of Preperimetric and Early Perimetric Glaucoma
Na KI
Journal of Glaucoma 2017; 26: 577-585 (IGR: 18-4)

73069 Comparison of isolated-check visual evoked potential and standard automated perimetry in early glaucoma and high-risk ocular hypertension
Zhao YX
International Journal of Ophthalmology 2017; 10: 599-604 (IGR: 18-4)

72749 Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma
Song YJ
Japanese Journal of Ophthalmology 2017; 61: 307-313 (IGR: 18-4)

72765 Diagnostic Ability of Wide-field Retinal Nerve Fiber Layer Maps Using Swept-Source Optical Coherence Tomography for Detection of Preperimetric and Early Perimetric Glaucoma
Kim YK
Journal of Glaucoma 2017; 26: 577-585 (IGR: 18-4)

72749 Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma
Kim YK
Japanese Journal of Ophthalmology 2017; 61: 307-313 (IGR: 18-4)

73168 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
Thenappan A
Ophthalmology 2017; 124: 1449-1456 (IGR: 18-4)

73146 Comparison of matrix frequency-doubling technology perimetry and standard automated perimetry in monitoring the development of visual field defects for glaucoma suspect eyes
Racette L
PLoS ONE 2017; 12: e0178079 (IGR: 18-4)

72749 Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma
Jeoung JW
Japanese Journal of Ophthalmology 2017; 61: 307-313 (IGR: 18-4)

72765 Diagnostic Ability of Wide-field Retinal Nerve Fiber Layer Maps Using Swept-Source Optical Coherence Tomography for Detection of Preperimetric and Early Perimetric Glaucoma
Jeoung JW
Journal of Glaucoma 2017; 26: 577-585 (IGR: 18-4)

73168 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
Girkin CA
Ophthalmology 2017; 124: 1449-1456 (IGR: 18-4)

72765 Diagnostic Ability of Wide-field Retinal Nerve Fiber Layer Maps Using Swept-Source Optical Coherence Tomography for Detection of Preperimetric and Early Perimetric Glaucoma
Park KH
Journal of Glaucoma 2017; 26: 577-585 (IGR: 18-4)

73168 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
Medeiros FA
Ophthalmology 2017; 124: 1449-1456 (IGR: 18-4)

72749 Development of visual field defect after first-detected optic disc hemorrhage in preperimetric open-angle glaucoma
Park KH
Japanese Journal of Ophthalmology 2017; 61: 307-313 (IGR: 18-4)

73168 24-2 Visual Fields Miss Central Defects Shown on 10-2 Tests in Glaucoma Suspects, Ocular Hypertensives, and Early Glaucoma
Weinreb RN; Zangwill LM; Liebmann JM
Ophthalmology 2017; 124: 1449-1456 (IGR: 18-4)

71465 Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma
Karaśkiewicz J
Documenta Ophthalmologica 2017; 134: 89-97 (IGR: 18-3)

71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Lerner SF
Journal of Ophthalmology 2017; 2017: 1917570 (IGR: 18-3)

71249 Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
Murphy ML
BMC Ophthalmology 2017; 17: 1 (IGR: 18-3)

71318 Choroidal thickness and structural glaucoma parameters in glaucomatous, preperimetric glaucomatous, and healthy eyes using swept-source OCT
Akil H
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-3)

71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Park KH
Journal of Ophthalmology 2017; 2017: 1917570 (IGR: 18-3)

71249 Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
Pokrovskaya O
BMC Ophthalmology 2017; 17: 1 (IGR: 18-3)

71318 Choroidal thickness and structural glaucoma parameters in glaucomatous, preperimetric glaucomatous, and healthy eyes using swept-source OCT
Al-Sheikh M
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-3)

71465 Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma
Penkala K
Documenta Ophthalmologica 2017; 134: 89-97 (IGR: 18-3)

71249 Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
Galligan M
BMC Ophthalmology 2017; 17: 1 (IGR: 18-3)

71318 Choroidal thickness and structural glaucoma parameters in glaucomatous, preperimetric glaucomatous, and healthy eyes using swept-source OCT
Falavarjani KG
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-3)

71465 Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma
Mularczyk M
Documenta Ophthalmologica 2017; 134: 89-97 (IGR: 18-3)

71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Hubatsch DA
Journal of Ophthalmology 2017; 2017: 1917570 (IGR: 18-3)

71465 Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma
Lubiński W
Documenta Ophthalmologica 2017; 134: 89-97 (IGR: 18-3)

71249 Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
O'Brien C
BMC Ophthalmology 2017; 17: 1 (IGR: 18-3)

71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Erichev V
Journal of Ophthalmology 2017; 2017: 1917570 (IGR: 18-3)

71318 Choroidal thickness and structural glaucoma parameters in glaucomatous, preperimetric glaucomatous, and healthy eyes using swept-source OCT
Francis B
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-3)

71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Paczka JA
Journal of Ophthalmology 2017; 2017: 1917570 (IGR: 18-3)

71318 Choroidal thickness and structural glaucoma parameters in glaucomatous, preperimetric glaucomatous, and healthy eyes using swept-source OCT
Chopra V
European Journal of Ophthalmology 2017; 0: 0 (IGR: 18-3)

71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Roberts TV
Journal of Ophthalmology 2017; 2017: 1917570 (IGR: 18-3)

70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Skaat A
Journal of Glaucoma 2016; 25: e807-e814 (IGR: 18-2)

70641 Resident Compliance With the American Academy of Ophthalmology Preferred Practice Patterns for Primary Open-Angle Glaucoma Suspect
Mihlstin M
Journal of Glaucoma 2016; 25: 963-967 (IGR: 18-2)

70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Jasien JV
Journal of Glaucoma 2016; 25: e807-e814 (IGR: 18-2)

70641 Resident Compliance With the American Academy of Ophthalmology Preferred Practice Patterns for Primary Open-Angle Glaucoma Suspect
Juzych MS
Journal of Glaucoma 2016; 25: 963-967 (IGR: 18-2)

70072 Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Ritch R
Journal of Glaucoma 2016; 25: e807-e814 (IGR: 18-2)

70641 Resident Compliance With the American Academy of Ophthalmology Preferred Practice Patterns for Primary Open-Angle Glaucoma Suspect
Kromrei HT; Hwang FS; Yin J
Journal of Glaucoma 2016; 25: 963-967 (IGR: 18-2)

69023 Tafluprost Ophthalmic Solution 0.0015 %: A Review in Glaucoma and Ocular Hypertension
Keating GM
Clinical Drug Investigation 2016; 36: 499-508 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Chabi A
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Yarmohammadi A
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Reznicek L
Current Eye Research 2016; 0: 1-6 (IGR: 18-1)

69305 Differentiation of ocular hypertension
Hoffmann EM
Ophthalmologe 2016; 113: 715-728 (IGR: 18-1)

68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Salvetat ML
Eye 2016; 30: 784-795 (IGR: 18-1)

69002 Assessing Precision of Hodapp-Parrish-Anderson Criteria for Staging Early Glaucomatous Damage in an Ocular Hypertension Cohort: A Retrospective Study
Chakravarti T
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 0: (IGR: 18-1)

69320 Technology and the Glaucoma Suspect
Blumberg DM
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5 (IGR: 18-1)

69077 Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye
Yoo E
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1599-1608 (IGR: 18-1)

69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Aptel F
Current Medical Research and Opinion 2016; 32: 1457-1463 (IGR: 18-1)

69465 Diagnosis and treatment of ocular hypertension
Sun YY; Chen WW
Chinese Journal of Ophthalmology 2016; 52: 542-546 (IGR: 18-1)

69320 Technology and the Glaucoma Suspect
De Moraes CG
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Zangwill LM
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

69077 Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye
Yoo C
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1599-1608 (IGR: 18-1)

69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Muth D
Current Eye Research 2016; 0: 1-6 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Baranak C
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Choudhry R
Current Medical Research and Opinion 2016; 32: 1457-1463 (IGR: 18-1)

68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Zeppieri M
Eye 2016; 30: 784-795 (IGR: 18-1)

69305 Differentiation of ocular hypertension
Lamparter J
Ophthalmologe 2016; 113: 715-728 (IGR: 18-1)

69077 Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye
Lee TE
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1599-1608 (IGR: 18-1)

69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Stalmans I
Current Medical Research and Opinion 2016; 32: 1457-1463 (IGR: 18-1)

69320 Technology and the Glaucoma Suspect
Liebmann JM
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5 (IGR: 18-1)

69465 Diagnosis and treatment of ocular hypertension
Wang NL
Chinese Journal of Ophthalmology 2016; 52: 542-546 (IGR: 18-1)

69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Vogel M
Current Eye Research 2016; 0: 1-6 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Diniz-Filho A
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Lupinacci R
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Tosoni C
Eye 2016; 30: 784-795 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Suh MH
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Herring WJ
International Journal of Clinical Pract 2016; 70: 577-586 (IGR: 18-1)

69077 Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye
Kim YY
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 1599-1608 (IGR: 18-1)

69333 Structure-Function Relationship between Flicker-Defined form Perimetry and Spectral-Domain Optical Coherence Tomography in Glaucoma Suspects
Hirneiß C
Current Eye Research 2016; 0: 1-6 (IGR: 18-1)

68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up
Brusini P
Eye 2016; 30: 784-795 (IGR: 18-1)

69320 Technology and the Glaucoma Suspect
Garg R; Chen C
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Manalastas PI
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

68950 Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up

Eye 2016; 30: 784-795 (IGR: 18-1)

69320 Technology and the Glaucoma Suspect
Theventhiran A
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Fatehee N; Yousefi S
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

69320 Technology and the Glaucoma Suspect
Hood DC
Investigative Ophthalmology and Visual Science 2016; 57: OCT80-5 (IGR: 18-1)

69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Belghith A; Saunders LJ; Medeiros FA; Huang D; Weinreb RN
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9 (IGR: 18-1)

66936 Treatment of ocular hypertension: is it cost effective?
Tuulonen A
Current Opinions in Ophthalmology 2016; 27: 89-93 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Wang YE
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67097 Comparison of diagnostic capability of macular ganglion cell complex and retinal nerve fiber layer among primary open angle glaucoma, ocular hypertension, and normal population using Fourier-domain optical coherence tomography and determining their functi
Barua N
Indian Journal of Ophthalmology 2016; 64: 296-302 (IGR: 17-4)

67225 Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis
Stroh IG
Ocular Immunology and Inflammation 2016; 0: 1-10 (IGR: 17-4)

66651 Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
Bozic MM
Indian Journal of Ophthalmology 2016; 64: 114-117 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Caminal JM
Eye 2016; 30: 833-842 (IGR: 17-4)

67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Stevens A
Clinical Ophthalmology 2016; 10: 635-641 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
Hua R
Scientific reports 2016; 6: 21743 (IGR: 17-4)

67474 Effect of Morphological and Functional Parameters on Ocular Pulse Amplitudes: An Analysis in Ocular Hypertension and Different Types of Glaucoma
Milioti G
Klinische Monatsblätter für Augenheilkunde 2017; 234: 223-230 (IGR: 17-4)

67269 Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease
Saboo US
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 923-928 (IGR: 17-4)

67097 Comparison of diagnostic capability of macular ganglion cell complex and retinal nerve fiber layer among primary open angle glaucoma, ocular hypertension, and normal population using Fourier-domain optical coherence tomography and determining their functi
Sitaraman C
Indian Journal of Ophthalmology 2016; 64: 296-302 (IGR: 17-4)

67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Iliev ME
Clinical Ophthalmology 2016; 10: 635-641 (IGR: 17-4)

67225 Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis
Moradi A
Ocular Immunology and Inflammation 2016; 0: 1-10 (IGR: 17-4)

67269 Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease
Amparo F
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 923-928 (IGR: 17-4)

67474 Effect of Morphological and Functional Parameters on Ocular Pulse Amplitudes: An Analysis in Ocular Hypertension and Different Types of Glaucoma
Langenbucher A
Klinische Monatsblätter für Augenheilkunde 2017; 234: 223-230 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
Gangwani R
Scientific reports 2016; 6: 21743 (IGR: 17-4)

66651 Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
Dukic ML
Indian Journal of Ophthalmology 2016; 64: 114-117 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Kakigi C
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Padrón-Pérez N
Eye 2016; 30: 833-842 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
Guo L
Scientific reports 2016; 6: 21743 (IGR: 17-4)

67474 Effect of Morphological and Functional Parameters on Ocular Pulse Amplitudes: An Analysis in Ocular Hypertension and Different Types of Glaucoma
Seitz B
Klinische Monatsblätter für Augenheilkunde 2017; 234: 223-230 (IGR: 17-4)

67097 Comparison of diagnostic capability of macular ganglion cell complex and retinal nerve fiber layer among primary open angle glaucoma, ocular hypertension, and normal population using Fourier-domain optical coherence tomography and determining their functi
Goel S
Indian Journal of Ophthalmology 2016; 64: 296-302 (IGR: 17-4)

67225 Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis
Burkholder BM
Ocular Immunology and Inflammation 2016; 0: 1-10 (IGR: 17-4)

66651 Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patients
Stojkovic MZ
Indian Journal of Ophthalmology 2016; 64: 114-117 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Barbosa D
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
de Jong L
Clinical Ophthalmology 2016; 10: 635-641 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Arias L
Eye 2016; 30: 833-842 (IGR: 17-4)

67269 Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease
Shikari H; Dana R
Graefe's Archive for Clinical and Experimental Ophthalmology 2016; 254: 923-928 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Masuet-Aumatell C
Eye 2016; 30: 833-842 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Porco T
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Grobeiu I
Clinical Ophthalmology 2016; 10: 635-641 (IGR: 17-4)

67225 Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis
Hornbeak DM
Ocular Immunology and Inflammation 2016; 0: 1-10 (IGR: 17-4)

67097 Comparison of diagnostic capability of macular ganglion cell complex and retinal nerve fiber layer among primary open angle glaucoma, ocular hypertension, and normal population using Fourier-domain optical coherence tomography and determining their functi
Chakraborti C
Indian Journal of Ophthalmology 2016; 64: 296-302 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
McGhee S
Scientific reports 2016; 6: 21743 (IGR: 17-4)

67474 Effect of Morphological and Functional Parameters on Ocular Pulse Amplitudes: An Analysis in Ocular Hypertension and Different Types of Glaucoma
Löw U
Klinische Monatsblätter für Augenheilkunde 2017; 234: 223-230 (IGR: 17-4)

67517 A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Hommer A
Clinical Ophthalmology 2016; 10: 635-641 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
Ma X
Scientific reports 2016; 6: 21743 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Gutiérrez C
Eye 2016; 30: 833-842 (IGR: 17-4)

67097 Comparison of diagnostic capability of macular ganglion cell complex and retinal nerve fiber layer among primary open angle glaucoma, ocular hypertension, and normal population using Fourier-domain optical coherence tomography and determining their functi
Mukherjee S
Indian Journal of Ophthalmology 2016; 64: 296-302 (IGR: 17-4)

67225 Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis
Leung TG
Ocular Immunology and Inflammation 2016; 0: 1-10 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Chen R
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67225 Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis
Thorne JE
Ocular Immunology and Inflammation 2016; 0: 1-10 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Piulats JM
Eye 2016; 30: 833-842 (IGR: 17-4)

67097 Comparison of diagnostic capability of macular ganglion cell complex and retinal nerve fiber layer among primary open angle glaucoma, ocular hypertension, and normal population using Fourier-domain optical coherence tomography and determining their functi
Parashar H
Indian Journal of Ophthalmology 2016; 64: 296-302 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Wang S
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
Li J
Scientific reports 2016; 6: 21743 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Li Y
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

66778 Detection of preperimetric glaucoma using Bruch membrane opening, neural canal and posterior pole asymmetry analysis of optical coherence tomography
Yao K
Scientific reports 2016; 6: 21743 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Pera J
Eye 2016; 30: 833-842 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Singh K
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Català J; Rubio MJ
Eye 2016; 30: 833-842 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Pasquale LR
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

67190 Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma
Arruga J
Eye 2016; 30: 833-842 (IGR: 17-4)

66708 Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States
Lin SC
Ophthalmology 2016; 123: 729-736 (IGR: 17-4)

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Zhang X
American Journal of Ophthalmology 2016; 163: 29-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Hernández R
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

66214 Glaucoma Suspect: Diagnosis and Management
Chang RT; Singh K
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2016; 5: 32-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Burr JM
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Loewen N
American Journal of Ophthalmology 2016; 163: 29-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Vale L
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Tan O; Greenfield DS
American Journal of Ophthalmology 2016; 163: 29-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Azuara-Blanco A; Cook JA
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Schuman JS; Varma R
American Journal of Ophthalmology 2016; 163: 29-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Banister K; Tuulonen A
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography
Huang D
American Journal of Ophthalmology 2016; 163: 29-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective
Ryan M
British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

65862 Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography

American Journal of Ophthalmology 2016; 163: 29-37 (IGR: 17-3)

66362 Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective

British Journal of Ophthalmology 2016; 100: 1263-1268 (IGR: 17-3)

61275 Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension
Christopher M
Investigative Ophthalmology and Visual Science 2015; 56: 4470-4479 (IGR: 17-1)

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Inuzuka H
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)

60993 Artificial Neural Network Approach for Differentiating Open-Angle Glaucoma From Glaucoma Suspect Without a Visual Field Test
Oh E
Investigative Ophthalmology and Visual Science 2015; 56: 3957-3966 (IGR: 17-1)

61275 Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension
Abràmoff MD
Investigative Ophthalmology and Visual Science 2015; 56: 4470-4479 (IGR: 17-1)

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Kawase K
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)

60993 Artificial Neural Network Approach for Differentiating Open-Angle Glaucoma From Glaucoma Suspect Without a Visual Field Test
Yoo TK
Investigative Ophthalmology and Visual Science 2015; 56: 3957-3966 (IGR: 17-1)

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Sawada A
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)

61275 Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension
Tang L
Investigative Ophthalmology and Visual Science 2015; 56: 4470-4479 (IGR: 17-1)

60993 Artificial Neural Network Approach for Differentiating Open-Angle Glaucoma From Glaucoma Suspect Without a Visual Field Test
Hong S
Investigative Ophthalmology and Visual Science 2015; 56: 3957-3966 (IGR: 17-1)

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Kokuzawa S
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)

61275 Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension
Gordon MO; Kass MA
Investigative Ophthalmology and Visual Science 2015; 56: 4470-4479 (IGR: 17-1)

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Ishida K
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)

61275 Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension
Budenz DL
Investigative Ophthalmology and Visual Science 2015; 56: 4470-4479 (IGR: 17-1)

61705 Development of Glaucomatous Visual Field Defects in Preperimetric Glaucoma Patients Within 3 Years of Diagnosis
Yamamoto T
Journal of Glaucoma 2016; 25: e591-e595 (IGR: 17-1)

61275 Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension
Fingert JH; Scheetz TE
Investigative Ophthalmology and Visual Science 2015; 56: 4470-4479 (IGR: 17-1)

59986 Ocular hypertension: an approach to assessment and management
Boey PY
Canadian Journal of Ophthalmology 2014; 49: 489-496 (IGR: 16-4)

60134 Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
Park KH
BMC Ophthalmology 2014; 14: 160 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Chan PP; Leung CK
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

59986 Ocular hypertension: an approach to assessment and management
Mansberger SL
Canadian Journal of Ophthalmology 2014; 49: 489-496 (IGR: 16-4)

60134 Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
Simonyi S; Kim CY
BMC Ophthalmology 2014; 14: 160 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Chiu V
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

60134 Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
Sohn YH
BMC Ophthalmology 2014; 14: 160 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Gangwani R
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

60134 Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting
Kook MS
BMC Ophthalmology 2014; 14: 160 (IGR: 16-4)

60583 Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma
Sharma A; So S; Congdon N
British Journal of Ophthalmology 2015; 99: 1245-1250 (IGR: 16-4)

59099 Longitudinal Changes in Peripapillary Atrophy in the Ocular Hypertension Treatment Study: A Case-Control Assessment
Savatovsky E; Mwanza JC; Budenz DL; Feuer WJ; Vandenbroucke R; Schiffman JC; Anderson DR;
Ophthalmology 2015; 122: 79-86 (IGR: 16-3)

59415 Identifying "preperimetric" glaucoma in standard automated perimetry visual fields
Asaoka R; Iwase A; Hirasawa K; Murata H; Araie M
Investigative Ophthalmology and Visual Science 2014; 55: 7814-7820 (IGR: 16-3)

59323 Confocal Laser Scanning Tomography to Predict Visual Field Conversion in Patients With Ocular Hypertension and Early Glaucoma
Schrems-Hoesl LM; Schrems WA; Laemmer R; Horn FK; Juenemann AG; Kruse FE; Mardin CY
Journal of Glaucoma 2016; 25: 371-376 (IGR: 16-3)

59615 Predictive Value of Heidelberg Retina Tomograph Parameters for the Development of Glaucoma in the European Glaucoma Prevention Study
Miglior S; Zeyen T; Hoffmann EM; Torri V; Rulli E; Floriani I; Poli D; Aliyeva S; Cunha-Vaz J; Pfeiffer N
American Journal of Ophthalmology 2015; 159: 265-76.e1 (IGR: 16-3)

59505 Six-year incidence of ocular hypertension in a South Indian population: the Chennai eye disease incidence study
Panday M; George R; Asokan R; Ramesh SV; Velumuri L; Choudhari NS; Boddupalli SD; Sunil GT; Vijaya L
British Journal of Ophthalmology 2015; 99: 604-608 (IGR: 16-3)

59426 Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysis
Xing Y; Jiang FG; Li T
International Journal of Ophthalmology 2014; 7: 879-890 (IGR: 16-3)

56893 Topographic profiles of retinal nerve fiber layer defects affect the diagnostic performance of macular scans in preperimetric glaucoma
Kim MJ; Jeoung JW; Park KH; Choi YJ; Kim DM
Investigative Ophthalmology and Visual Science 2014; 55: 2079-2087 (IGR: 16-2)

57434 Metabolic syndrome as a risk factor for elevated intraocular pressure
Sahinoglu-Keskek N; Keskek SO; Cevher S; Kirim S; Kayiklik A; Ortoglu G; Saler T
Pakistan journal of medical sciences 2014; 30: 477-482 (IGR: 16-2)

56441 Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma Suspect Eyes
Miki A; Medeiros FA; Weinreb RN; Jain S; He F; Sharpsten L; Khachatryan N; Hammel N; Liebmann JM; Girkin CA; Sample PA; Zangwill LM
Ophthalmology 2014; 121: 1350-1358 (IGR: 16-1)

55539 External validation of the OHTS-EGPS model for predicting the 5-year risk of open-angle glaucoma in ocular hypertensives
Takwoingi Y; Botello AP; Burr JM; Azuara-Blanco A; Garway-Heath DF; Lemij HG; Sanders R; King AJ; Deeks JJ;
British Journal of Ophthalmology 2014; 98: 309-314 (IGR: 15-4)

53626 Effect of ageing on the retinal vascular responsiveness to flicker light in glaucoma patients and in ocular hypertension
Gugleta K; Türksever C; Polunina A; Orgül S
British Journal of Ophthalmology 2013; 97: 848-851 (IGR: 15-2)

53802 Features of optic disc progression in patients with ocular hypertension and early glaucoma
Lloyd MJ; Mansberger SL; Fortune BA; Nguyen H; Torres R; Demirel S; Gardiner SK; Johnson CA; Cioffi GA
Journal of Glaucoma 2013; 22: 343-348 (IGR: 15-2)

54060 The central corneal thickness in normal tension glaucoma, primary open angle glaucoma and ocular hypertension
Shetgar AC; Mulimani MB
Journal of clinical and diagnostic research : JCDR 2013; 7: 1063-1067 (IGR: 15-2)

53875 Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
Day DG; Walters TR; Schwartz GF; Mundorf TK; Liu C; Schiffman RM; Bejanian M
British Journal of Ophthalmology 2013; 97: 989-993 (IGR: 15-2)

54015 A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
Pfennigsdorf S; de Jong L; Makk S; Fournichot Y; Bron A; Morgan-Warren RJ; Maltman J
Clinical Ophthalmology 2013; 7: 1219-1225 (IGR: 15-2)

53628 Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefe's Archive for Clinical and Experimental Ophthalmology 2013; 251: 2019-2028 (IGR: 15-2)

52373 Ocular Hypertension and the Risk of Blindness
Gestel AV; Webers CA; Beckers HJ; Peeters A; Severens JL; Schouten JS
Journal of Glaucoma 2015; 24: 9-11 (IGR: 15-1)

51232 Optometry-based general population survey of pupil ruff atrophy and ocular hypertension
Ang GS; Stevenson PJ; Sargent G; Grimmer P; Corbett P; Jourdain E; Wells AP
Clinical and Experimental Ophthalmology 2013; 41: 360-367 (IGR: 14-3)

51059 Frequency doubling technology, optical coherence technology and pattern electroretinogram in ocular hypertension
Cellini M; Toschi PG; Strobbe E; Balducci N; Campos EC
BMC Ophthalmology 2012; 12: 33 (IGR: 14-3)

50789 Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open-angle glaucoma
Shazly TA; Latina MA; Dagianis JJ; Chitturi S
Cornea 2012; 31: 883-886 (IGR: 14-3)

50688 Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches
Orme M; Collins S; Loftus J
Journal of Glaucoma 2012; 21: 433-449 (IGR: 14-3)

50482 Risk Calculation Variability Over Time in Ocular Hypertensive Subjects
Song C; De Moraes CG; Forchheimer I; Prata TS; Ritch R; Liebmann JM
Journal of Glaucoma 2014; 23: 1-4 (IGR: 14-2)

50403 An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthalmic Solution and Xalatan in Patients With Glaucoma or Ocular Hypertension
Digiuni M; Manni G; Vetrugno M; Uva M; Milano G; Orzalesi N; Fogagnolo P; Centofanti M; Campos E; Rossetti L
Journal of Glaucoma 2013; 22: 707-712 (IGR: 14-2)

50465 Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Pfennigsdorf S; Ramez O; von Kistowski G; Mä,der B; Eschstruth P; Frobö,se M; Thelen U; Spraul C; Schnober D; Cooper H; Laube T
Clinical Ophthalmology 2012; 6: 739-746 (IGR: 14-2)

50477 The Effect of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics in Patients With Ocular Hypertension and Primary Open-angle Glaucoma
Beltran-Agullo L; Alaghband P; Obi A; Husain R; Lim KS
Journal of Glaucoma 2013; 22: 746-749 (IGR: 14-2)

50515 Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
Burr JM; Botello-Pinzon P; Takwoingi Y; Herná,ndez R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J.
Health Technol Assess 2012; 16: 1-271 (IGR: 14-2)

48607 Application of optical coherence tomography in glaucoma suspect eyes
Pomorska M; Krzyżanowska-Berkowska P; Misiuk-Hojło M; Zając-Pytrus H; Grzybowski A,
Clinical and Experimental Optometry 2012; 95: 78-88 (IGR: 14-1)

48548 Comparison of newly diagnosed ocular hypertension and open-angle glaucoma: ocular variables, risk factors, and disease severity
Buys YM; Harasymowycz P; Gaspo R; Kwok K; Hutnik CM; Blondeau P; Birt CM; Piemontesi RL; Gould LF; Lesk MR; Ahmed IK
Journal of Ophthalmology 2012; 2012: 757106 (IGR: 14-1)

49166 Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group
De Moraes CG; Demirel S; Gardiner SK; Liebmann JM; Cioffi GA; Ritch R; Gordon MO; Kass MA;
Investigative Ophthalmology and Visual Science 2012; 53: 1704-1709 (IGR: 14-1)

48790 Latanoprost 0.005% test formulation is as effective as Xalatan® in patients with ocular hypertension and primary open-angle glaucoma
Allaire C; Dietrich A; Allmeier H; Grundmane I; Mazur-Piotrowska G; Neshev P; Kahle G
European Journal of Ophthalmology 0; 22: 19-27 (IGR: 14-1)

48868 Shared care of patients with ocular hypertension in the Community and Hospital Allied Network Glaucoma Evaluation Scheme (CHANGES)
Mandalos A; Bourne R; French K; Newsom W; Chang L
Eye 2012; 26: 564-567 (IGR: 14-1)

46872 Quality of life in ocular hypertension and primary open angle glaucoma
Wolfram C; Lorenz K; Shlaen R; Verboven Y; Pfeiffer N
Value in Health 2010; 13: A402 (IGR: 13-3)

46803 Assessment of Corneal Biomechanical Properties in Normal Tension Glaucoma and Comparison With Open-angle Glaucoma, Ocular Hypertension, and Normal Eyes
Grise-Dulac A; Saad A; Abitbol O; Febbraro J-L; Azan E; Moulin-Tyrode C; Gatinel D
Journal of Glaucoma 2011; (IGR: 13-3)

46947 Comparison of visual field results of humphrey matrix perimetry and standard automated perimetry with SITA strategy in glaucoma and ocular hypertension subjects
Yilmaz PT; Bozkurt B; Irkec M
Turk Oftalmoloiji Dergisi 2011; 41: 98-103 (IGR: 13-3)

27132 Aqueous humor dynamics in inbred rhesus monkeys with naturally occurring ocular hypertension
Toris CB; Risma JM; Gonzales-Martinez J; McLaughlin MA; Dawson WW
Experimental Eye Research 2010; 91: 860-865 (IGR: 12-4)

26940 Longitudinal and Cross-sectional Analyses of Visual Field Progression in Participants of the Ocular Hypertension Treatment Study
PH Artes; BC Chauhan; JL Keltner; KE Cello; CA Johnson; DR Anderson; MO Gordon; MA Kass
Archives of Ophthalmology 2010; 128: 1528-1532 (IGR: 12-4)

27531 Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma
Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
Clinical and Experimental Ophthalmology 2010; 38: 678-682 (IGR: 12-4)

26325 Predicting the onset of glaucoma the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study
Weinreb RN; Zangwill LM; Jain S; Becerra LM; Dirkes K; Piltz-Seymour JR; Cioffi GA; Trick GL; Coleman AL; Brandt JD
Ophthalmology 2010; 117: 1674-1683 (IGR: 12-3)

26140 Horizontal deviation of retinal nerve fiber layer peak thickness with stratus optical coherence tomography in glaucoma patients and glaucoma suspects
Lee JC; Shields MB
Journal of Glaucoma 2010; 19: 299-303 (IGR: 12-2)

26139 Predicting progression to glaucoma in ocular hypertensive patients
Strouthidis NG; Gardiner SK; Owen VM; Zuniga C; Garway-Heath DF
Journal of Glaucoma 2010; 19: 304-309 (IGR: 12-2)

25961 Ability of optical imaging devices to detect early structural damage in ocular hypertension
Pueyo V; Polo V; Larrosa JM; Pablo LE; Ferreras A; Honrubia FM
Annals of ophthalmology (Skokie, Ill.) 2009; 41: 150-156 (IGR: 12-2)

25723 Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension
Gugleta K
Current Medical Research and Opinion 2010; 26: 1255-1267 (IGR: 12-2)

25607 Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma
Peeters A; Webers C A B; Prins M H; Zeegers M P; Hendrikse F; Schouten J S A G
Acta Ophthalmologica 2010; 88: 5-11 (IGR: 12-1)

25547 Observation of ocular hypertension in thirty-two patients
Li C; Li W -N
International Journal of Ophthalmology 2010; 10: 175-176 (IGR: 12-1)

25627 Delaying Treatment of Ocular Hypertension: The Ocular Hypertension Treatment Study
Kass MA; Gordon MO; Gao F; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JK; Miller JP; Parrish RK; Wilson MR
Archives of Ophthalmology 2010; 128: 276-287 (IGR: 12-1)

21460 Central corneal thickness measurements in ocular hypertension, primary open angle glaucoma, glaucoma suspects and control subjects
Atanassov MA; Konareva-Kostianeva MI
Folia Medica 2008; 50: 35-39 (IGR: 10-3)

21222 Comparative results of central corneal thickness measurements in primary open-angle glaucoma, pseudoexfoliation glaucoma, and ocular hypertension
Gorezis S; Christos G; Stefaniotou M; Moustaklis K; Skyrlas A; Kitsos G
Ophthalmic Surgery Lasers and Imaging 2008; 39: 17-21 (IGR: 10-2)

21401 Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma
Medeiros FA; Weinreb RN; Zangwill LM; Alencar LM; Sample PA; Vasile C; Bowd C
Ophthalmology 2008; 115: 934-940 (IGR: 10-2)

21220 Comparison of optical coherence tomography and scanning laser polarimetry in glaucoma, ocular hypertension, and suspected glaucoma
Halkiadakis I; Kipioti A; Emfietzoglou I; Grigoropoulos V; Katsis A; Alimisi S; Vergados I; Theodossiadis P; Theodossiadis GP
Ophthalmic Surgery Lasers and Imaging 2008; 39: 125-132 (IGR: 10-2)

21071 Ocular pulse amplitude in patients with open-angle glaucoma, normal-tension glaucoma, and ocular hypertensionby dynamic observing tonometry
Kawabata K; Kimura T; Fujiki K; Murakami A
Nippon Ganka Gakkai Zasshi 2007; 111: 946-952 (IGR: 10-2)

21162 The prevalence of glaucomatous risk factors in patients from a managed care setting: A pilot evaluation
Fang EN; Law SK; Walt JG; Chiang TH; Williams EN
American Journal of Managed Care 2008; 14: S28-S36 (IGR: 10-2)

20542 Importance of central corneal thickness when studying ocular hypertensive eyes, glaucoma suspects and preperimetric glaucomatous eyes
Alias Alegre EG; Ferreras A; Polo V; Larrosa JM; Pueyo V; Honrubia FM
Archivos de la Sociedad Española de Oftalmologia 2007; 82: 615-621 (IGR: 10-1)

20854 Effects of Central Corneal Thickness on the Efficacy of Topical Ocular Hypotensive Medications
Johnson TV; Toris CB; Fan S; Camras CB
Journal of Glaucoma 2008; 17: 89-99 (IGR: 10-1)

20648 Central thickness of the cornea in ocular hypertension and open-angle glaucoma
Chiselita D; Danielescu C; Gagos-Zaharia O; Gherman C
Oftalmologia 2007; 51: 98-103 (IGR: 10-1)

20832 Stratus-OCT imaging in early glaucomatous and in ocular hypertensive patients with and without frequency-doubling technology abnormalities
Brusini P; Zeppieri M; Tosoni C; Parisi L; Felletti M; Salvetat ML
Eye 2008; 22: 406-413 (IGR: 10-1)

20390 Risk factors for incident open-angle glaucoma: the Barbados Eye Studies
Leske MC; Wu SY; Hennis A; Honkanen R; Nemesure B; BESs Study Group
Ophthalmology 2008; 115: 85-93 (IGR: 10-1)

20712 Fixed-combination latanoprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: An update
Feldman RM
Salud (i) Ciencia 2007; 15: 1100-1107 (IGR: 10-1)

20827 Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist
Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
Eye 2008; 22: 354-362 (IGR: 10-1)

20389 Cost-effectiveness of treating ocular hypertension
Stewart WC; Stewart JA; Nassar QJ; Mychaskiw MA
Ophthalmology 2008; 115: 94-98 (IGR: 10-1)

20557 When is glaucoma really glaucoma?
San Laureano J
Clinical and Experimental Optometry 2007; 90: 376-385 (IGR: 10-1)

19792 Importance of structural examination methods in the follow-up of patients with ocular hypertension
Skorkovska K
Česka a Slovenska Oftalmologie 2007; 63: 335-349 (IGR: 9-4)

19560 Quantification of neuroretinal rim loss using digital planimetry in long-term follow-up of normals and patients with ocular hypertension
Laemmer R; Schroeder S; Martus P; Viestenz A; Mardin CY
Journal of Glaucoma 2007; 16: 430-436 (IGR: 9-3)

19469 Optical coherence tomography, frequency-doubling technology, and colour Doppler imaging in ocular hypertension
Cellini M; Bernabini B; Carbonelli M; Zamparini E; Campos EC
Eye 2007; 21: 1071-1077 (IGR: 9-3)

19497 Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study
Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I; EGPS Group
American Journal of Ophthalmology 2007; 144: 266-275 (IGR: 9-3)

17486 Predicting visual field loss in ocular hypertensive patients using wavelet-fourier analysis of GDx scanning laser polarimetry
Essock EA; Gunvant P; Zheng Y; Garway-Heath DF; Kotecha A; Spratt A
Optometry and Vision Science 2007; 84: E380-E387 (IGR: 9-2)

18190 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension
Hepsen IF; Ozkaya E
Eye 2007; 21: 453-458 (IGR: 9-2)

17120 Specular microscopy of the corneal endothelial in hypertension patients
Di Y; Wang Q-Q; Wu H-L; Yan Q-C
International Journal of Ophthalmology 2006; 6: 1336-1338 (IGR: 9-1)

16973 Measurement of autofluorescence in the parapapillary atrophic zone in patients with ocular hypertension
Laemmer R; Horn FK; Viestenz A; Link B; Juenemann AG; Mardin CY
Graefe's Archive for Clinical and Experimental Ophthalmology 2007; 245: 51-58 (IGR: 9-1)

16875 Agreement between stereophotographic and confocal scanning laser ophthalmoscopy measurements of cup/disc ratio: Effect on a predictive model for glaucoma development
Medeiros FA; Zangwill LM; Bowd C; Vasile C; Sample PA; Weinreb RN
Journal of Glaucoma 2007; 16: 209-214 (IGR: 9-1)

16922 Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study
European Glaucoma Prevention Study (EGPS) Group; Miglior S; Pfeiffer N; Torri V; Zeyen T; Cunha-Vaz J; Adamsons I
Ophthalmology 2007; 114: 3-9 (IGR: 9-1)

16753 Evolving global risk assessment of ocular hypertension to glaucoma
Fechtner RD; Khouri AS
Current Opinions in Ophthalmology 2007; 18: 104-109 (IGR: 9-1)

16938 Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension
Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group; Gordon MO; Torri V; Miglior S; Beiser JA; Floriani I; Miller JP; Gao F; Adamsons I
Ophthalmology 2007; 114: 10-19 (IGR: 9-1)

16759 Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma
Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
British Journal of Ophthalmology 2007; 91: 62-68 (IGR: 9-1)

16823 Midterm response with latanoprost therapy in german ocular hypertension patients
Thelen U; Christ T; Schnober D; Hofstetter HJ; Stewart WC
Current Eye Research 2007; 32: 51-56 (IGR: 9-1)

15269 Relationship between short wavelength perimetry and central corneal thickness values in ocular hypertensive subjects
Dadaci Z; Bozkurt B; Irkec MT; Orhan M; Arslan U
European Journal of Ophthalmology 2006; 16: 667-673 (IGR: 8-4)

15170 Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study
Budenz DL; Anderson DR; Feuer WJ; Beiser JA; Schiffman J; Parrish RK 2nd; Piltz-Seymour JR; Gordon MO; Kass MA; Ocular Hypertension Treatment Study Group
Ophthalmology 2006; 113: 2137-2143 (IGR: 8-4)

15140 Pattern ERG as an early glaucoma indicator in ocular hypertension: a long-term, prospective study
Bach M; Unsoeld AS; Philippin H; Staubach F; Maier P; Walter HS; Bomer TG; Funk J
Investigative Ophthalmology and Visual Science 2006; 47: 4881-4887 (IGR: 8-4)

15147 Study of patients with ocular hypertension with scanning laser polarimetry and short-wavelength automatic perimetry
Georgopoulos GT; Halkiadakis I; Patsea E; Papakonstantinou D; Alexiou M; Vergados I; Andreanos D; Theodossiadis G; Moschos M
Ophthalmologica 2006; 220: 361-367 (IGR: 8-4)

15187 The probability of glaucoma from ocular hypertension determined by ophthalmologists in comparison to a risk calculator
Mansberger SL; Cioffi GA
Journal of Glaucoma 2006; 15: 426-431 (IGR: 8-4)

15148 Inconsistency of the published definition of ocular hypertension
Tavares IM; Medeiros FA; Weinreb RN
Journal of Glaucoma 2006; 15: 529-533 (IGR: 8-4)

14062 Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement
Strouthidis NG; Scott A; Peter NM; Garway-Heath DF
Investigative Ophthalmology and Visual Science 2006; 47: 2904-2910 (IGR: 8-3)

14038 Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study
Levine RA; Demirel S; Fan J; Keltner JL; Johnson CA; Kass MA
Investigative Ophthalmology and Visual Science 2006; 47: 3896-3903 (IGR: 8-3)

14078 The French glaucoma and ocular hypertension 1-day study
Villain M; Nordmann JP; Renard JP; Bron A; Delcourt C; Pinchinat S; Solesse De Gendre A; Pelen F
Journal Français d'Ophtalmologie 2006; 29: 520-525 (IGR: 8-3)

12998 Ocular hypertension and corneal thickness: a long-term prospective study. Results after two years
Brusini P; Tosoni C; Parisi L; Rizzi L
European Journal of Ophthalmology 2005; 15: 550-555 (IGR: 7-3)

13095 Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study
Zangwill LM; Weinreb RN; Beiser JA; Berry CC; Cioffi GA; Coleman AL; Trick G; Liebmann JM; Brandt JD; Piltz-Seymour JR
Archives of Ophthalmology 2005; 123: 1188-1197 (IGR: 7-3)

13054 Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study
Keltner JL; Johnson CA; Levine RA; Fan J; Cello KE; Kass MA; Gordon MO
Archives of Ophthalmology 2005; 123: 1201-1206 (IGR: 7-3)

12718 Correlation of blue-on-yellow perimetry and corneal thickness in ocular hypertension patients
Zhong Y; Gao J; Xiang M; Cai K; Chen L
Chinese Ophthalmic Research 2005; 23: 516-518 (IGR: 7-3)

13052 Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma
Medeiros FA; Weinreb RN; Sample PA; Gomi CF; Bowd C; Crowston JG; Zangwill LM
Archives of Ophthalmology 2005; 123: 1351-1360 (IGR: 7-3)

12173 Nomogram for ocular hypertension progression risk based on the ocular hypertension treatment study
Diaz Aleman VT; Fernandez Baca Vaca G; Lozano Lopez V; Garcia Somalo M; Perera Sanz D; Gonzalez de la Rosa M
Archivos de la Sociedad Española de Oftalmologia 2005; 80: 151-154 (IGR: 7-2)

12483 Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension
Bengtsson B; Heijl A
Graefe's Archive for Clinical and Experimental Ophthalmology 2005; 243: 513-518 (IGR: 7-2)

12503 Evaluation of risk factors for advanced glaucoma in Ghanaian patients
Ntim Amponsah CT; Amoaku WM; Ewusi RK; Idirisuriya Khair R; Nyatepe Coo E; Ofosu Amaah S
Eye 2005; 19: 528-534 (IGR: 7-2)

12114 A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension
Bengtsson B; Heijl A
Journal of Glaucoma 2005; 14: 135-138 (IGR: 7-1)

11885 Results of the European Glaucoma Prevention Study
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I; European Glaucoma Prevention Study (EGPS) Group
Ophthalmology 2005; 112: 366-375 (IGR: 7-1)

11341 Factors associated with optic disc hemorrhages in glaucoma
Soares AS; Artes PH; Andreou P; Leblanc RP; Chauhan BC; Nicolela MT
Ophthalmology 2004; 111: 1653-1657 (IGR: 6-3)

10796 Diurnal variation in microcirculation of ocular fundus and visual field change in normal-tension glaucoma
Okuno T; Sugiyama T; Kojima S; Nakajima M; Ikeda T
Eye 2004; 18: 697-702 (IGR: 6-2)

10508 Five-year risk of progression of ocular hypertension to primary open angle glaucoma: a population-based study
Thomas R; Parikh R; George R; Kumar RS; Muliyil J
Indian Journal of Ophthalmology 2003; 51: 329-333 (IGR: 6-1)

8459 Case control study on the risk factors of primary open angle glaucoma in China
Wang N; Peng Z; Fan B; Liu Y; Dong X; Liang X; Luan J
Zhonghua Liu Xing Bing Xue Za Zhi 2002; 23: 293-296 (IGR: 5-1)

8125 The European glaucoma prevention study design and baseline description of the participants
No authors listed
Ophthalmology 2002; 109: 1612-1621 (IGR: 4-3)

3406 Aqueous humor dynamics in ocular hypertensive patients
Toris CB; Koepsell SA; Yablonski ME; Camras CB
Journal of Glaucoma 2002; 11: 253-258 (IGR: 4-2)

3703 The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma
Gordon MO; Beiser JA; Brandt JD; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish 2nd TK; Wilson R
Archives of Ophthalmology 2002; 120: 714-720; discussion 829-830 (IGR: 4-2)

3520 The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish 2nd RK; Wilson MR; Gordon MO
Archives of Ophthalmology 2002; 120: 701-713 (IGR: 4-2)

6724 Baseline visual field characteristics in the ocular hypertension treatment study
Johnson CA; Keltner JL; Cello KE; Edwards M; Kass MA; Gordon MO; Budenz DL; Gaasterland DE; Werner E
Ophthalmology 2002; 109: 432-437 (IGR: 4-1)

6759 Eye tension and open angle glaucoma in a Burkina Faso hospital
Daboue A; Meda ND; Ahnoux Zabsonre A
Journal Français d'Ophtalmologie 2002; 25: 39-41 (IGR: 4-1)

18431 Effect of scleral expansion band on ocular hypertension: Canadian phase 1 study
Rifkind AW; Yablonski ME; Shuster JJ
Compr Ther 2001; 27: 333-340 (IGR: 3-3)

6317 Central corneal thickness measurements in patients with normal tension glaucoma, primary open angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension
Sobottka Ventura AC; Böhnke M; Mojon DS
British Journal of Ophthalmology 2001; 85: 792-795 (IGR: 3-2)

6418 An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A
Journal Français d'Ophtalmologie 2001; 24: 233-243 (IGR: 3-2)

15966 Large diurnal fluctuations in intraocular pressure are an independent riskfactor in patients with glaucoma.
Becker B
Journal of Glaucoma 2000; 9: 487-8 (IGR: 2-3)

15690 Visual field progression in patients with initially unilateral visual field loss from chronic open-angle glaucoma
Chen PP; Park RJ
Ophthalmology 2000; 107: 1688-1692 (IGR: 2-3)

15873 Contralateral effect of topical β-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study
Piltz J; Gross R; Shin DH; Beiser JA; Dorr DA; Kass MA; Gordon MO
American Journal of Ophthalmology 2000; 130: 441-453 (IGR: 2-3)

6027 Optic disc size in ocular hypertension
Sekhar GC; Nagarajan R; Naduvilath TJ; Dandona L; Rao KM; Rao VD
Indian Journal of Ophthalmology 1999; 47: 229-231 (IGR: 2-2)

5571 Increased intraocular pressure and visual field defects in high resistance wind instrument players
Schuman JS; Massicotte EC; Connolly S; Hertzmark E; Mukherji B; Kunen MZ
Ophthalmology 2000; 107:127-133 (IGR: 2-1)

5708 Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma
Asrani S; Zeimer R; Wilensky J; Gieser D; Vitale S; Lindenmuth K
Journal of Glaucoma 2000; 9: 134-142 (IGR: 2-1)